Cite
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus.
MLA
Draulans, Cédric, et al. “Stereotactic Body Radiation Therapy with Optional Focal Lesion Ablative Microboost in Prostate Cancer: Topical Review and Multicenter Consensus.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 140, Nov. 2019, pp. 131–42. EBSCOhost, https://doi.org/10.1016/j.radonc.2019.06.023.
APA
Draulans, C., De Roover, R., van der Heide, U. A., Haustermans, K., Pos, F., Smeenk, R. J., De Boer, H., Depuydt, T., Kunze-Busch, M., Isebaert, S., & Kerkmeijer, L. (2019). Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 140, 131–142. https://doi.org/10.1016/j.radonc.2019.06.023
Chicago
Draulans, Cédric, Robin De Roover, Uulke A van der Heide, Karin Haustermans, Floris Pos, Robert Jan Smeenk, Hans De Boer, et al. 2019. “Stereotactic Body Radiation Therapy with Optional Focal Lesion Ablative Microboost in Prostate Cancer: Topical Review and Multicenter Consensus.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 140 (November): 131–42. doi:10.1016/j.radonc.2019.06.023.